These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27398277)

  • 21. Market power in the United States red meatpacking industry.
    Koontz SR
    Vet Clin North Am Food Anim Pract; 2003 Jul; 19(2):519-44. PubMed ID: 12951745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-national drug price comparisons with economic weights in external reference pricing in Germany.
    Mahlich J; Sindern J; Suppliet M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):37-43. PubMed ID: 30273062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How fast are hospital prices really rising?
    Dranove D; Shanley M; White WD
    Med Care; 1991 Aug; 29(8):690-6. PubMed ID: 1875737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines].
    Barth J; Hammerschmidt T; Vollmar J; Bierbaum M; Schöffski O
    Gesundheitswesen; 2014 Apr; 76(4):e7-e13. PubMed ID: 24081570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 policy responses, inflation and spillover effects in the West African Economic and Monetary Union.
    Coulibaly S
    Afr Dev Rev; 2021 Apr; 33(Suppl 1):S139-S151. PubMed ID: 34149242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scenario simulation of the EU carbon price and its enlightenment to China.
    Li ZP; Yang L; Zhou YN; Zhao K; Yuan XL
    Sci Total Environ; 2020 Jun; 723():137982. PubMed ID: 32222500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sources of recent inflationary pressures and interlinkages between food and non-food prices in Ethiopia.
    Demeke H; Tenaw D
    Heliyon; 2021 Nov; 7(11):e08375. PubMed ID: 34825086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers' Compensation System.
    Wilson L; Turkistani F; Tran DM; Huang W; Lin TK
    Appl Health Econ Health Policy; 2019 Apr; 17(2):231-242. PubMed ID: 30484140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
    Roughead EE; Kim DS; Ong B; Kemp-Casey A
    WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prices for generics in Australia - more competition might help.
    Bulfone L
    Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy.
    Boivin R
    Int J Drug Policy; 2014 Mar; 25(2):235-43. PubMed ID: 24418633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: A before-and-after study.
    Silver LD; Ng SW; Ryan-Ibarra S; Taillie LS; Induni M; Miles DR; Poti JM; Popkin BM
    PLoS Med; 2017 Apr; 14(4):e1002283. PubMed ID: 28419108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Pharmaceutical Pricing Transparency Matter? Examining Brazil's Public Procurement System.
    Kohler JC; Mitsakakis N; Saadat F; Byng D; Martinez MG
    Global Health; 2015 Aug; 11():34. PubMed ID: 26238110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Drugs: An International Comparison of Postlicensing Price Inflation.
    Savage P; Mahmoud S; Patel Y; Kantarjian H
    J Oncol Pract; 2017 Jun; 13(6):e538-e542. PubMed ID: 28605615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Ophthalmic Medication Prices Between the United States and Australia.
    Parikh R; Feng PW; Tainsh L; Sakurada Y; Balaratnasingam C; Khurana RN; Hemmati H; Modi YS
    JAMA Ophthalmol; 2019 Apr; 137(4):358-362. PubMed ID: 30629105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oil price shocks, economic policy uncertainty and industrial economic growth in China.
    Chen J; Jin F; Ouyang G; Ouyang J; Wen F
    PLoS One; 2019; 14(5):e0215397. PubMed ID: 31075134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum alcohol pricing policies in practice: A critical examination of implementation in Canada.
    Thompson K; Stockwell T; Wettlaufer A; Giesbrecht N; Thomas G
    J Public Health Policy; 2017 Feb; 38(1):39-57. PubMed ID: 28275253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean Region.
    Salmasi S; Lee KS; Ming LC; Neoh CF; Elrggal ME; Babar ZD; Khan TM; Hadi MA
    BMC Cancer; 2017 Dec; 17(1):903. PubMed ID: 29282008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.